Micetal (Flutrimazole)

Flutrimazole is indicated for the treatment of fungal skin infections caused by dermatophytes and yeasts.

• Tinea pedis (athlete's foot): reduces fungal growth and alleviates itching, scaling and redness on the feet.
• Tinea corporis (ringworm): eliminates the causative fungus and promotes healing of circular skin lesions.
• Tinea cruris (jock itch): controls infection in the groin area, reducing irritation and rash.
• Candidal intertrigo: treats superficial Candida infections of skin folds, decreasing inflammation and discharge.

• Flutrimazole exerts its antifungal activity by inhibiting the fungal enzyme lanosterol 14α‑demethylase, a key component of the ergosterol biosynthesis pathway. Blocking this enzyme prevents the formation of ergosterol, an essential sterol for fungal cell membrane integrity, leading to increased membrane permeability, impaired cell growth and ultimately fungal cell death. The inhibition is concentration‑dependent and results in a fungistatic effect at lower concentrations and fungicidal activity with prolonged exposure.

Topical application of Flutrimazole may be associated with local skin reactions and, rarely, systemic adverse events.

Common Side Effects

• Mild burning sensation: transient feeling of heat at the application site.
• Pruritus: occasional itching of the treated skin.
• Erythema: mild redness around the area of use.

Serious or Rare Side Effects

• Severe allergic reaction: signs of angioedema, swelling or widespread rash requiring medical attention.
• Systemic toxicity: rare hepatic enzyme elevation if extensive absorption occurs.
• Anaphylaxis: extremely rare life‑threatening hypersensitivity.

When using Micetal topical Flutrimazole, certain precautions should be observed to ensure safety and effectiveness.

• Application area: apply only to intact, non‑broken skin affected by fungal infection.
• Concurrent products: avoid using other topical antifungals or irritants on the same area unless directed by a healthcare professional.
• Duration of therapy: discontinue after the recommended treatment period or if symptoms resolve, to minimize resistance risk.
• Pregnancy and lactation: consult a physician before use, as safety data are limited.
• Allergic history: do not use if known hypersensitivity to azole antifungals.
• Store at room temperature: keep the product in its original container, protect from moisture and direct sunlight.

Flutrimazole may interact with other medications, primarily through additive antifungal effects or systemic absorption.

Major Interactions (Avoid)

• Systemic azole antifungals (e.g., itraconazole, fluconazole): concurrent use can increase systemic exposure and risk of toxicity.
• Cytochrome P450 substrates with narrow therapeutic index: avoid combined use due to potential enzyme inhibition.

Moderate Interactions (Monitor Closely)

• Topical corticosteroids: may reduce antifungal efficacy if applied together.
• Skin irritants (e.g., harsh soaps, chemicals): may increase local irritation.
• Alcohol‑based hand sanitizers: can affect product integrity if applied shortly after use.